LBH-positive immunostaining was detected in 14 of 18 different CRC patient samples analyzed (Fig. 7A.i–ii; Fig. 7B; and data not shown), confirming LBH overexpression in colon cancer (Fig. 1; Fig. S1A). Here, LBH is linked to colonic neoplasm.